Report cover image

Global Genome Sequencing Service Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 04, 2026
Length 204 Pages
SKU # APRC20824056

Description

The global Genome Sequencing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Genome Sequencing Service include Illumina, Thermo Fisher Scientific, BGI Genomics, Agilent Technologies, CD Genomics, Azenta Life Sciences, Broad Clinical Labs, Macrogen and GE Healthcare Life Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Genome Sequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Genome Sequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Genome Sequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genome Sequencing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Genome Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Genome Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.

Genome Sequencing Service Segment by Company

Illumina
Thermo Fisher Scientific
BGI Genomics
Agilent Technologies
CD Genomics
Azenta Life Sciences
Broad Clinical Labs
Macrogen
GE Healthcare Life Sciences
Johnson & Johnson
Abbott Laboratories
Bayer
Microchip Biotechnologies
GeneDx
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Novogene
Eurofins Genomics
Psomagen

Genome Sequencing Service Segment by Type

Whole-Genome Sequencing
Whole exome Sequencing
Others

Genome Sequencing Service Segment by Application

Humanity
Plant
Animal
Microorganism
Virus

Genome Sequencing Service Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Genome Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Genome Sequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genome Sequencing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

204 Pages
1 Market Overview
1.1 Product Definition
1.2 Genome Sequencing Service Market by Type
1.2.1 Global Genome Sequencing Service Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Whole-Genome Sequencing
1.2.3 Whole exome Sequencing
1.2.4 Others
1.3 Genome Sequencing Service Market by Application
1.3.1 Global Genome Sequencing Service Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Humanity
1.3.3 Plant
1.3.4 Animal
1.3.5 Microorganism
1.3.6 Virus
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Genome Sequencing Service Market Dynamics
2.1 Genome Sequencing Service Industry Trends
2.2 Genome Sequencing Service Industry Drivers
2.3 Genome Sequencing Service Industry Opportunities and Challenges
2.4 Genome Sequencing Service Industry Restraints
3 Global Growth Perspective
3.1 Global Genome Sequencing Service Market Perspective (2021-2032)
3.2 Global Genome Sequencing Service Growth Trends by Region
3.2.1 Global Genome Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Genome Sequencing Service Market Size by Region (2021-2026)
3.2.3 Global Genome Sequencing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Genome Sequencing Service Revenue by Players
4.1.1 Global Genome Sequencing Service Revenue by Players (2021-2026)
4.1.2 Global Genome Sequencing Service Revenue Market Share by Players (2021-2026)
4.1.3 Global Genome Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Genome Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Genome Sequencing Service Key Players Headquarters & Area Served
4.4 Global Genome Sequencing Service Players, Product Type & Application
4.5 Global Genome Sequencing Service Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Genome Sequencing Service Market CR5 and HHI
4.6.3 2025 Genome Sequencing Service Tier 1, Tier 2, and Tier 3
5 Genome Sequencing Service Market Size by Type
5.1 Global Genome Sequencing Service Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Genome Sequencing Service Revenue by Type (2021-2032)
5.3 Global Genome Sequencing Service Revenue Market Share by Type (2021-2032)
6 Genome Sequencing Service Market Size by Application
6.1 Global Genome Sequencing Service Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Genome Sequencing Service Revenue by Application (2021-2032)
6.3 Global Genome Sequencing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Company Information
7.1.2 Illumina Business Overview
7.1.3 Illumina Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.1.4 Illumina Genome Sequencing Service Product Portfolio
7.1.5 Illumina Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Information
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.2.4 Thermo Fisher Scientific Genome Sequencing Service Product Portfolio
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 BGI Genomics
7.3.1 BGI Genomics Company Information
7.3.2 BGI Genomics Business Overview
7.3.3 BGI Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.3.4 BGI Genomics Genome Sequencing Service Product Portfolio
7.3.5 BGI Genomics Recent Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Company Information
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.4.4 Agilent Technologies Genome Sequencing Service Product Portfolio
7.4.5 Agilent Technologies Recent Developments
7.5 CD Genomics
7.5.1 CD Genomics Company Information
7.5.2 CD Genomics Business Overview
7.5.3 CD Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.5.4 CD Genomics Genome Sequencing Service Product Portfolio
7.5.5 CD Genomics Recent Developments
7.6 Azenta Life Sciences
7.6.1 Azenta Life Sciences Company Information
7.6.2 Azenta Life Sciences Business Overview
7.6.3 Azenta Life Sciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.6.4 Azenta Life Sciences Genome Sequencing Service Product Portfolio
7.6.5 Azenta Life Sciences Recent Developments
7.7 Broad Clinical Labs
7.7.1 Broad Clinical Labs Company Information
7.7.2 Broad Clinical Labs Business Overview
7.7.3 Broad Clinical Labs Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.7.4 Broad Clinical Labs Genome Sequencing Service Product Portfolio
7.7.5 Broad Clinical Labs Recent Developments
7.8 Macrogen
7.8.1 Macrogen Company Information
7.8.2 Macrogen Business Overview
7.8.3 Macrogen Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.8.4 Macrogen Genome Sequencing Service Product Portfolio
7.8.5 Macrogen Recent Developments
7.9 GE Healthcare Life Sciences
7.9.1 GE Healthcare Life Sciences Company Information
7.9.2 GE Healthcare Life Sciences Business Overview
7.9.3 GE Healthcare Life Sciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.9.4 GE Healthcare Life Sciences Genome Sequencing Service Product Portfolio
7.9.5 GE Healthcare Life Sciences Recent Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Information
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.10.4 Johnson & Johnson Genome Sequencing Service Product Portfolio
7.10.5 Johnson & Johnson Recent Developments
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Company Information
7.11.2 Abbott Laboratories Business Overview
7.11.3 Abbott Laboratories Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.11.4 Abbott Laboratories Genome Sequencing Service Product Portfolio
7.11.5 Abbott Laboratories Recent Developments
7.12 Bayer
7.12.1 Bayer Company Information
7.12.2 Bayer Business Overview
7.12.3 Bayer Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.12.4 Bayer Genome Sequencing Service Product Portfolio
7.12.5 Bayer Recent Developments
7.13 Microchip Biotechnologies
7.13.1 Microchip Biotechnologies Company Information
7.13.2 Microchip Biotechnologies Business Overview
7.13.3 Microchip Biotechnologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.13.4 Microchip Biotechnologies Genome Sequencing Service Product Portfolio
7.13.5 Microchip Biotechnologies Recent Developments
7.14 GeneDx
7.14.1 GeneDx Company Information
7.14.2 GeneDx Business Overview
7.14.3 GeneDx Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.14.4 GeneDx Genome Sequencing Service Product Portfolio
7.14.5 GeneDx Recent Developments
7.15 Commonwealth Biotechnologies
7.15.1 Commonwealth Biotechnologies Company Information
7.15.2 Commonwealth Biotechnologies Business Overview
7.15.3 Commonwealth Biotechnologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.15.4 Commonwealth Biotechnologies Genome Sequencing Service Product Portfolio
7.15.5 Commonwealth Biotechnologies Recent Developments
7.16 ZS Genetics
7.16.1 ZS Genetics Company Information
7.16.2 ZS Genetics Business Overview
7.16.3 ZS Genetics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.16.4 ZS Genetics Genome Sequencing Service Product Portfolio
7.16.5 ZS Genetics Recent Developments
7.17 Pacific Biosciences
7.17.1 Pacific Biosciences Company Information
7.17.2 Pacific Biosciences Business Overview
7.17.3 Pacific Biosciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.17.4 Pacific Biosciences Genome Sequencing Service Product Portfolio
7.17.5 Pacific Biosciences Recent Developments
7.18 Novogene
7.18.1 Novogene Company Information
7.18.2 Novogene Business Overview
7.18.3 Novogene Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.18.4 Novogene Genome Sequencing Service Product Portfolio
7.18.5 Novogene Recent Developments
7.19 Eurofins Genomics
7.19.1 Eurofins Genomics Company Information
7.19.2 Eurofins Genomics Business Overview
7.19.3 Eurofins Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.19.4 Eurofins Genomics Genome Sequencing Service Product Portfolio
7.19.5 Eurofins Genomics Recent Developments
7.20 Psomagen
7.20.1 Psomagen Company Information
7.20.2 Psomagen Business Overview
7.20.3 Psomagen Genome Sequencing Service Revenue and Gross Margin (2021-2026)
7.20.4 Psomagen Genome Sequencing Service Product Portfolio
7.20.5 Psomagen Recent Developments
8 North America
8.1 North America Genome Sequencing Service Revenue (2021-2032)
8.2 North America Genome Sequencing Service Revenue by Type (2021-2032)
8.2.1 North America Genome Sequencing Service Revenue by Type (2021-2026)
8.2.2 North America Genome Sequencing Service Revenue by Type (2027-2032)
8.3 North America Genome Sequencing Service Revenue Share by Type (2021-2032)
8.4 North America Genome Sequencing Service Revenue by Application (2021-2032)
8.4.1 North America Genome Sequencing Service Revenue by Application (2021-2026)
8.4.2 North America Genome Sequencing Service Revenue by Application (2027-2032)
8.5 North America Genome Sequencing Service Revenue Share by Application (2021-2032)
8.6 North America Genome Sequencing Service Revenue by Country
8.6.1 North America Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Genome Sequencing Service Revenue by Country (2021-2026)
8.6.3 North America Genome Sequencing Service Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Genome Sequencing Service Revenue (2021-2032)
9.2 Europe Genome Sequencing Service Revenue by Type (2021-2032)
9.2.1 Europe Genome Sequencing Service Revenue by Type (2021-2026)
9.2.2 Europe Genome Sequencing Service Revenue by Type (2027-2032)
9.3 Europe Genome Sequencing Service Revenue Share by Type (2021-2032)
9.4 Europe Genome Sequencing Service Revenue by Application (2021-2032)
9.4.1 Europe Genome Sequencing Service Revenue by Application (2021-2026)
9.4.2 Europe Genome Sequencing Service Revenue by Application (2027-2032)
9.5 Europe Genome Sequencing Service Revenue Share by Application (2021-2032)
9.6 Europe Genome Sequencing Service Revenue by Country
9.6.1 Europe Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Genome Sequencing Service Revenue by Country (2021-2026)
9.6.3 Europe Genome Sequencing Service Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Genome Sequencing Service Revenue (2021-2032)
10.2 China Genome Sequencing Service Revenue by Type (2021-2032)
10.2.1 China Genome Sequencing Service Revenue by Type (2021-2026)
10.2.2 China Genome Sequencing Service Revenue by Type (2027-2032)
10.3 China Genome Sequencing Service Revenue Share by Type (2021-2032)
10.4 China Genome Sequencing Service Revenue by Application (2021-2032)
10.4.1 China Genome Sequencing Service Revenue by Application (2021-2026)
10.4.2 China Genome Sequencing Service Revenue by Application (2027-2032)
10.5 China Genome Sequencing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Genome Sequencing Service Revenue (2021-2032)
11.2 Asia Genome Sequencing Service Revenue by Type (2021-2032)
11.2.1 Asia Genome Sequencing Service Revenue by Type (2021-2026)
11.2.2 Asia Genome Sequencing Service Revenue by Type (2027-2032)
11.3 Asia Genome Sequencing Service Revenue Share by Type (2021-2032)
11.4 Asia Genome Sequencing Service Revenue by Application (2021-2032)
11.4.1 Asia Genome Sequencing Service Revenue by Application (2021-2026)
11.4.2 Asia Genome Sequencing Service Revenue by Application (2027-2032)
11.5 Asia Genome Sequencing Service Revenue Share by Application (2021-2032)
11.6 Asia Genome Sequencing Service Revenue by Country
11.6.1 Asia Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Genome Sequencing Service Revenue by Country (2021-2026)
11.6.3 Asia Genome Sequencing Service Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Genome Sequencing Service Revenue (2021-2032)
12.2 SAMEA Genome Sequencing Service Revenue by Type (2021-2032)
12.2.1 SAMEA Genome Sequencing Service Revenue by Type (2021-2026)
12.2.2 SAMEA Genome Sequencing Service Revenue by Type (2027-2032)
12.3 SAMEA Genome Sequencing Service Revenue Share by Type (2021-2032)
12.4 SAMEA Genome Sequencing Service Revenue by Application (2021-2032)
12.4.1 SAMEA Genome Sequencing Service Revenue by Application (2021-2026)
12.4.2 SAMEA Genome Sequencing Service Revenue by Application (2027-2032)
12.5 SAMEA Genome Sequencing Service Revenue Share by Application (2021-2032)
12.6 SAMEA Genome Sequencing Service Revenue by Country
12.6.1 SAMEA Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Genome Sequencing Service Revenue by Country (2021-2026)
12.6.3 SAMEA Genome Sequencing Service Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.